Rob starts the week with a look at an old reliable on the Daily Stock Watch!

While it didn’t take down the tournament, BR Vengevine made waves on the Pro Tour coverage. Adrian looks at cards slated for increases in response to the new arrival to Modern.

While Journey Into Nyx is unlikely to unseat the top decks in Standard, it does enable a few new strategies. Mike Lanigan investigates.